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Abstract
Aims: The goal of the current study was to determine whether the sphingosine kinase 1 (SK1)/sphingosine-1-phosphate
(S1P) pathway is involved in myogenic vasoconstriction under normal physiological conditions. In the present study, we
assessed whether endogenous S1P generated by pressure participates in myogenic vasoconstriction and which signaling
pathways are involved in SK1/S1P-induced myogenic response under normal physiological conditions.
Methods and Results: We measured pressure-induced myogenic response, Ca
2+ concentration, and 20 kDa myosin light
chain phosphorylation (MLC20) in rabbit posterior cerebral arteries (PCAs). SK1 was expressed and activated by elevated
transmural pressure in rabbit PCAs. Translocation of SK1 by pressure elevation was blocked in the absence of external Ca
2+
and in the presence of mechanosensitive ion channel and voltage-sensitive Ca
2+ channel blockers. Pressure-induced
myogenic tone was inhibited in rabbit PCAs treated with sphingosine kinase inhibitor (SKI), but was augmented by
treatment with NaF, which is an inhibitor of sphingosine-1-phosphate phosphohydrolase. Exogenous S1P further
augmented pressure-induced myogenic responses. Pressure induced an increase in Ca
2+ concentration leading to the
development of myogenic tone, which was inhibited by SKI. Exogenous S1P further increased the pressure-induced
increased Ca
2+ concentration and myogenic tone, but SKI had no effect. Pressure- and exogenous S1P-induced myogenic
tone was inhibited by pre-treatment with the Rho kinase inhibitor and NADPH oxidase inhibitors. Pressure- and exogenous
S1P-induced myogenic tone were inhibited by pre-treatment with S1P receptor blockers, W146 (S1P1), JTE013 (S1P2), and
CAY10444 (S1P3). MLC20 phosphorylation was increased when the transmural pressure was raised from 40 to 80 mmHg and
exogenous S1P further increased MLC20 phosphorylation. The pressure-induced increase of MLC20 phosphorylation was
inhibited by pre-treatment of arteries with SKI.
Conclusions: Our results suggest that the SK1/S1P pathway may play an important role in pressure-induced myogenic
responses in rabbit PCAs under normal physiological conditions.
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Introduction
The myogenic response is an intrinsic vascular response
characterized by vasoconstriction in response to an increase in
intravascular pressure and vasodilation in response to a decrease in
intravascular pressure [1]. Arterial myogenic tone plays an
important role in establishing ambient vascular tone and auto-
regulating blood flow in the resistance vasculature, especially in
cerebral circulation [2–4], because cerebral arteries are not
particularly responsive to the sympathetic nerves surrounding
them [5].
The biologically active sphingomyelin metabolite, sphingosine-
1-phosphate (S1P), generated by the enzyme sphingosine kinase 1
(SK1), is present in plasma at high nanomolar concentrations,
released from activated platelets [6,7], and found in increased
quantities in inflammation and atherosclerosis [8]. S1P plays an
important role as a vascular modulator [9–11], and most effects of
S1P are mediated by a family of five highly specific G-protein–
coupled receptors called S1P receptors [12]. It was reported that
the myogenic responses of isolated resistance arteries were
increased in the smooth muscle cells of SK1-transfected arteries
[12,13]. It was also reported that myogenic vasoconstriction in
response to increased transmural pressure was significantly
reduced in resistance arteries transfected with sphingosine-1-
phosphate phosphohydrolase 1 (SPP1), a S1P-degrading enzyme
[14]. Taken together, these results suggest that SK1 and its
product, S1P, may be involved in the pressure-induced signaling
cascade leading to myogenic vasoconstriction. However, whether
SK1/S1P contributes to pressure-induced myogenic responses
under normal physiological conditions is unknown.
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35177Cerebral vasospasm is a sustained abnormal contraction of the
cerebral arteries [15,16]. Several spasmogenic substances in-
cluding oxyhemoglobin, endothelin-1, thrombin, serotonin, nor-
adrenalin, and thromboxane have been suggested [17,18].
Sphingolipids have been suggested as candidate spasmogenic
substances because they are released from activated platelets and
are found at high levels in inflammation and predisposing
situations for vasospasm [17]. Therefore, the changes in vascular
contractility, including myogenic tone, induced by sphingolipids in
cerebral arteries should be determined. We already reported the
augmentation of cerebral arterial tone by sphingolipid metabolites
as well as the underlying mechanisms [19]. Therefore, the role of
the SK1/S1P pathway in pressure-induced myogenic tone and the
underlying mechanisms remain to be elucidated.
The goal of this study was to determine whether SK1/S1P
participates in pressure-induced myogenic responses under normal
physiological conditions and which signaling pathways are involved
in SK1/S1P-induced myogenic responses. We examined the effect
of endogenous and exogenous S1P on myogenic responses. We
measured the contribution of endogenous S1P on myogenic
response upon vasoconstriction induced by activated SK1 when
transmural pressure was increased, and the effect of exogenous S1P
was evaluated as vasoconstriction was induced by treatment with
S1P in a bath solution at elevated transmural pressure.
Methods
This investigation conformed to the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of
Health (NIH publication No. 85–23, revised in 1996). The
experimental protocols used in this study were reviewed and
approved by the Ethics Committee and Institutional Animal Care
and Use Committee of Yonsei University College of Medicine.
1.1. Tissue Preparation
New Zealand white rabbits were used in this study and
anesthetized with sodium pentobarbital (50 mg/kg, IV injection)
containing, heparin (2000 IU/kg), an anticoagulant. The rabbit
brains were removed and placed in a normal Krebs-Henseleit
(KH) solution composed of the following substances (in mmol/L):
NaCl, 119; CaCl2, 2.5; NaHCO3, 25; MgSO4, 1.2; KH2PO4, 1.2;
KCl, 4.6; and glucose, 11.1. The KH solution was continuously
aerated with a 95% O2-5% CO2 gas mixture. The rabbit posterior
cerebral arteries (PCAs) were dissected and their segments of about
3–4 mm in length were prepared.
1.2. Measurement of Myogenic Tone Using an
Arteriograph System
Rabbit PCA segments (100–250 mm inner diameter and 3–
4 mm in length) were dissected, cannulated in a pressure
myograph (Living Systems Instrumentation, Burlington, VT,
USA) filled with KH solution, and subsequently placed on the
stage of an inverted microscope (Eclipse TS100/TS100-F, Nikon
Inc., Melville, NY, USA). The proximal cannula was connected to
a solid-state pressure transducer and reservoir of KH solution, and
the transmural pressure was controlled by a pressure servo-
controller. The distal cannula was connected to a luer-lock valve
that was opened to flush the lumen during the initial cannulation.
After cannulation, the valve was closed, and all measurements
were conducted under no-flow conditions. The arterial lumen
diameter was recorded using the SoftEdge Acquisition Subsystem
(IonOptix, Milton, MA, USA).
The KH perfusing and superfusing in the arterial segments was
equilibrated with a 95% O2-5% CO2 gas mixture at 37uC. To
eliminate the potential influence of endothelial factors on the
pressure-induced myogenic tone, an air bolus was passed through
the lumen to disrupt the endothelium. The function of the
endothelium was checked at the beginning of each experiment
with 10
–6 M acetylcholine in arteries pre-contracted with 70 mM
K
+ solution (equimolar substitution of Na
+ with K
+).
After being mounted, the de-endothelialized cerebral arterial
segments were stretched longitudinally to approximate the in situ
length and were maintained at a transmural pressure of
40 mmHg for a 40–60 min equilibration period. After the
equilibration period, the pressure was increased in a stepwise
manner from 20 to 100 mmHg in 20-mmHg increments, and
each pressure was maintained for 10 min to allow blood vessel
diameter to stabilize before measurement. In some experiments,
an abbreviated myogenic protocol was used. The arteries were
equilibrated and constricted as described above, but the initial
pressure was 40 mmHg and was increased to 80 mmHg. After
a series of step changes, the transmural pressure was returned to
40 mmHg and the vessel was allowed to re-equilibrate for
a minimum of 40 min. At the end of each experiment, a passive
pressure-diameter relationship was established in Ca
2+-free KH
solution containing 0.1 mmol/L nifedipine to determine the
maximum passive diameter. When the effects of drugs on
myogenic responses were assessed, they were administered at
a transmural pressure of 40 mmHg 15–30 min before increasing
the luminal pressure.
Responses to changes in transmural pressure were normalized
as a percentage of the initial diameter at 40 mmHg to control for
changes in the resting tone caused by the drugs. The following
formula was used to calculate the percent myogenic tone at each
pressure step: percent myogenic tone = {(DpX/Dp40) 2 (DaX/
Da40)}6100, where DpX and Dp40 are the passive diameters at
a given pressure and 40 mmHg in Ca
2+-free PSS (0 mM Ca
2+
with 0.1 mmol/L nifedipine), respectively, and DaX and Da40 are
the active diameters at a given pressure and 40 mmHg in normal
PSS in the presence of extracellular Ca
2+, respectively.
1.3. Measurement of Smooth Muscle Ca
2+ in Pressurized
Arteries
Rabbit PCA segments were loaded with the Fura-2AM
(10 mmol/L; Molecular Probes, Eugene, OR, USA), the Ca
2+-
sensitive fluorescent indicator, and 0.02% cremophor EL (Sigma,
St Louis, MO, USA) in KH as previously reported [20]. The
arteries were incubated in this solution for 3 h at room
temperature in the dark. Fura-2AM-loaded PCA segments were
mounted in a pressure myograph and pressurized to 40 mmHg
using a pressure-servo controller and then superfused with KH
(37uC) that was aerated with 95% O2 + 5% CO2 to wash out the
excess dye and to allow for hydrolysis of the AM groups by
intracellular esterases. The transmural pressure of the arteries was
then elevated to 80 mmHg. Fura-2-loaded vessels were alternately
excited at 340 and 380 nm at a frequency of 1 Hz with an
IonOptix Hyperswitch dual excitation light source, and the
respective emissions at 510 nm were detected with a photomulti-
plier tube. Background-subtracted 340/380 emission ratios were
calculated using IonOptix Ion Wizard software and recorded
continuously throughout the experiment. The fluorescent emission
at 510 nm (R340/380) and the changes in arterial diameter,
monitored by video microscopy (IonOptix), were recorded
simultaneously.
1.4. Immunofluorescence of SK1 in PCA
The localization of SK1 in isolated rabbit PCAs was measured
using immunostaining as described previously [21]. PCAs were
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1.5. Western Blotting
The expression of SK1 and S1P receptor proteins in rabbit
PCAs were measured by western blot as described previously [19].
Membranes were probed with SK1 antibody (1:200, Millipore),
S1P receptors (1:200, Millipore), and actin antibody (1:5,000,
Abcam, Cambridge, UK) was used as a loading control.
1.6. MLC20 Phosphorylation Measurements
Phosphorylation of the 20 kDa myosin light chain (MLC20)i n
the rabbit PCA was measured as described previously [19]. Vessels
were rapidly removed from the pressure myograph and frozen
when myogenic responses were stable after changes in transmural
pressure from 40 mmHg to 80 mmHg. For each preparation,
vessels from three to four animals were pooled. Membranes were
probed with a specific phosphor-MLC20 monoclonal antibody
(1:100; Cell Signaling, Boston, MA, USA) and total MLC20
antibody (1:200; Cell Signaling).
1.7. Drugs
The following drugs were used: S1P (Sigma), SKI (EIPA; Sigma,
St Louis, MO, USA), NaF (Sigma), (R)-3-Amino-(3-hexylpheny-
lamino)-4-oxobutylphosphonic acid (W146) (Sigma), 1-[1,3-Di-
methyl-4-(2-methylethyl)-1H-pyrazolo[3,4-b]pyridine-6-yl]-4-(3,5-
dichloro-4-pyridinyl)-semicarbazide (JTE013) (Tocris Bioscience,
Ellisville, MO, USA), 2-undecyl-thiazolidine-4-carboxylic acid
(CAY10444) (Cayman Chemical, Ann Arbor, MI, USA), fasudil
hydrochloride (Tocris), DPI (Sigma), apocynin (Sigma), 1-[b-[3-(4-
methoxyphenyl)propoxy]-4-methoxyphenethyl]-1H-imidazole hy-
drochloride (SKF-96365) (Tocris Bioscience), 9-phenanthrol
(Sigma), and nifedipine (Sigma). The general laboratory reagents
used were analytical grade or better. S1P was dissolved in 100%
ethanol. SKF96365 and 9-phenanthrol were dissolved in dimethyl
sulfoxide (DMSO) to a maximum final DMSO concentration of
0.1% that had no effect on vascular tone (data not shown).
1.8. Statistics
All values given in the text were expressed as mean6SEMs and
analyzed by one-way and two-way ANOVA, followed by the
Student-Newman-Keuls post-hoc test. Differences were consid-
ered significant at the P,0.05 level.
Results
2.1. Activation of SK1 by Transmural Pressure Elevation
We first determined whether SK1 is expressed in rabbit PCAs
using western blot analysis. The western blots used to detect SK1
expression in isolated rabbit PCAs are shown in Figure 1A. SK1
antibodies were labeled as a major band around 50 kDa in isolated
PCAs, basilar arteries (BAs), middle cerebral arteries (MCAs), and
internal carotid arteries (ICAs).
We also determined whether SK1 is activated by pressure
elevation. Elevation of transmural pressure from 40 to 80 mmHg
was associated with translocation of SK1 from the cytosol to the
plasma membrane (Figure 1B). Translocation of SK1 by pressure
elevation was blocked in the absence of external Ca
2+ (Ca
2+-free
KH solution; Figure 1C1). Translocation of SK1 by pressure
elevation was also blocked in the presence of mechanosensitive ion
channel blockers, 1 mmol/L amiloride (epithelial Na
+ channel
blocker), 5 mmol/L 9-phenanthrol (selective TRPM4 blocker), and
10 mmol/L SKF 96365 (nonselective blocker of TRPC channels)
(Figure 1C2). Nifedipine, a voltage-sensitive Ca
2+ channel blocker,
also blocked translocation of SK1 by elevation of transmural
pressure from 40 to 80 mmHg (Figure 1C3).
2.2. Role of Endogenous and Exogenous S1P in Myogenic
Tone
To determine whether endogenous S1P generated by trans-
mural pressure elevation is involved in the development of
myogenic tone, we evaluated myogenic tone in the presence of
5 mmol/L SKI, an inhibitor of SK1 (Figures 2A & B1), and
1 mmol/L NaF, an inhibitor of the S1P-degrading enzyme,
sphingosine-1 phosphate phosphohydrolase (SPP) (Figure 2B2).
The myogenic response induced by increased transmural pressure
(stepwise from 20 to 100 mmHg) was decreased in the presence of
SKI (n=9), but it was increased in the presence of NaF (n=6).
To determine the effect of exogenous S1P on myogenic tone, we
evaluated myogenic tone in isolated rabbit PCA in the presence
and absence of exogenous S1P (1 mmol/L; Figure 2B3). The
myogenic response elicited by a pressure increase from 20 to
100 mmHg was elevated in the presence of exogenous S1P (n=5).
We also determined the effect of pre-treatment of S1P on SKI-
induced inhibitory effect of myogenic tone. As shown in Figure 2C,
the SKI inhibited myogenic responses induced by increased
transmural pressure (from 40 to 80 mmHg). Pre-treatment of S1P
decreased blood vessel diameter and abolished the SKI-induced
inhibitory effect of myogenic tone. These results suggest that an
increase in transmural pressure activates SK1, which then
increases endogenous S1P. Furthermore, our results suggest that
endogenous and exogenous S1P are involved in the development
of myogenic tone.
In control experiments, there were no significant differences
between two consecutive pressure-induced myogenic responses
(data not shown). In addition, to determine the EC50 for S1P, SKI,
and NaF, we generated a concentration-response curve for these
drugs at a 80 mmHg transmural pressure. The EC50 values were
1.28 mM for S1P, 5.49 mM for SKI, and 1.01 mM for NaF (data
not shown).
To determine the role of endothelium on endogenous and
exogenous S1P-induced myogenic tone, we compared myogenic
tone between the presence and absence of endothelium in isolated
rabbit PCAs. As shown in Figure 2D, raising the transmural
pressure from 40 to 80 mmHg developed myogenic tone and
pressure-induced myogenic tone was similar between endothelium
denuded (27.1 6 5.8, n=5) and intact (29.7 6 5.0, n=5) arteries.
Exogenous S1P-induced myogenic tone was also similar between
endothelium denuded (63.9 6 5.9, n=5) and intact (66.7 6 7.5,
n=5) arteries. SKI (1 mmol/L) significantly (P,0.05, n=5)
inhibited the pressure-induced development of myogenic tone
and the inhibitory effect was not different between endothelium
denuded and intact arteries. However, SKI had no significant
effect on S1P-induced myogenic tone in endothelium denuded and
intact arteries (Figure 2D; n=5).
2.3. Mechanisms Underlying Endogenous and Exogenous
S1P-induced Myogenic Tone
We first determined the influence of S1P on the changes in
Ca
2+ concentration by measuring vascular wall Ca
2+ concen-
tration using Fura-2AM, the fluorescence ion indicator. As
shown in Figure 3, raising the transmural pressure from 40 to
80 mmHg increased Ca
2+ fluorescence intensity. Application of
exogenous S1P further increased Ca
2+ fluorescence intensity.
The increase in Ca
2+ fluorescence intensity was accompanied by
the development of myogenic tone (Figure 3A1; n=6). To
determine whether blockading SK1, the S1P-generating en-
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2+ fluorescence intensity, we
measured the effect of SKI pretreatment on changes in Ca
2+
fluorescence intensity. SKI (1 mmol/L) significantly (P,0.05,
n=6) inhibited the pressure-induced increase in Ca
2+ fluores-
cence intensity and development of myogenic tone (Figures 3A2
and B1). However, SKI had no significant effect on the S1P-
induced increase in Ca
2+ fluorescence intensity and myogenic
tone (Figures 3A2 and B2; n=5).
To assess the possible involvement of Ca
2+ sensitization of the
contractile apparatus (Ca
2+ sensitization) pathway, we evaluated
the role of RhoA/Rho kinase and NADPH oxidase/reactive
oxygen substrate (ROS) on endogenous and exogenous S1P-
induced myogenic tone (Figure 4). Fasudil (1 mmol/L), the Rho
kinase inhibitor, significantly (P,0.05, n=5) inhibited pressure-
and exogenous S1P-induced myogenic tone (Figures 4B1 and
B2). Inhibition of NADPH oxidase with 10 mmol/L DPI,
a broad chemical inhibitor of signaling pathways unrelated to
ROS generation, significantly (P,0.05, n=6) reduced pressure-
and exogenous S1P-induced myogenic tone (Figures 4A, C1 and
C2). Furthermore, apocynin, a specific chemical inhibitor of
NADPH oxidase, also significantly (P,0.05, n=5) reduced
pressure- and exogenous S1P-induced myogenic tone
(Figures 4D1 and D2).
2.4. S1P Receptors Mediate the Effects of Exogenous and
Endogenous S1P
Three S1P receptors (S1P1–3; formerly known as Edg1, Edg5,
and Edg3) are expressed in rabbit PCA (Figure 5A). These S1P
receptors are also expressed in BAs, MCAs, and ICAs. To
determine which S1P receptors are involved in endogenous and
exogenous S1P-induced changes in myogenic tone, we evaluated
myogenic tone in isolated rabbit PCAs in the presence and
absence of specific S1P receptor blockers. As shown in
Figures 5B and C, pretreatment with 1 mmol/L W146 (S1P1
blocker; Figure 5C1; n=6), 1 mmol/L JTE013 (S1P2 blocker;
Figure 5C2; n=6), and 1 mmol/L CAY10444 (S1P3 blocker;
Figure 5C3; n=5) significantly (P,0.05) inhibited not only
pressure-induced myogenic tone, but also S1P-induced myogen-
ic tone. The extent of inhibition was similar among the S1P
receptor blockers.
2.5. 20 kDa Myosin Light Chain ( MLC20) Phosphorylation
and Myogenic Tone
To determine the possible downstream effectors of myogenic
tone, we measured MLC20 phosphorylation in steady-state
myogenic tone. As shown in Figure 6, MLC20 phosphorylation
increased significantly (P,0.05, n=5) when the transmural
pressure was raised from 40 to 80 mmHg. The level of MLC20
phosphorylation induced by pressure was similar to the high K
+-
induced MLC20 phosphorylation level. However, the pressure-
induced increase in MLC20 phosphorylation was significantly
inhibited (P,0.05, n=5) by pre-treatment of the arteries with
SKI. The pressure-induced increase in MLC20 phosphorylation
was further increased by application of exogenous S1P when the
pressure-induced myogenic tone had stabilized. SKI also signifi-
cantly (P,0.05, n=5) reduced the exogenous S1P-induced
increase in MLC20 phosphorylation. However, the pressure-
induced increase in MLC20 phosphorylation in arteries treated
with S1P and SKI was higher than that in arteries treated with
SKI alone.
Figure 1. Expression and activation of SK1 by elevated of transmural pressure. A: Western blot analysis of SK1 expression in rabbit vessels.
Representative western blots of SK1 and actin in isolated rabbit posterior cerebral arteries (PCAs), basilar arteries (BAs), middle cerebral arteries
(MCAs), and internal carotid arteries (ICA). B: SK1 iImmunofluorescence in isolated rabbit posterior cerebral arteries at 40 and 80 mmHg. C: SK1
immunofluorescence at pressure elevation (80 mmHg) in the absence of external Ca
2+ (C1) and in the presence of mechanosensitive ion channel (C2),
and voltage-sensitive Ca
2+ channel blockers (C3).
doi:10.1371/journal.pone.0035177.g001
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A previous report indicated that the SK1, S1P-generating
enzyme, can function as a mechanotransducer [12–14]. However,
whether the SK1/S1P pathway was involved in myogenic
vasoconstriction under normal physiological conditions was not
determined. Furthermore, mechanisms underlying SK1/S1P
pathway-induced myogenic tone were not fully elucidated.
The results of the present study suggest that the SK1/S1P
pathway plays an important role in myogenic tone. The major
findings of this study are as follows: 1) SK1 is expressed and
activated in response to transmural pressure elevation in rabbit
PCAs. Translocation of SK1 is dependent on Ca
2+ influx via
activation of voltage-sensitive Ca
2+ channels following depolariza-
tion by activation of mechanosensitice ion channels; 2) pressure-
induced myogenic tone is inhibited in rabbit PCAs treated with
sphingosine kinase inhibitor (SKI), but augmented by treatment
with NaF, an inhibitor of SPP1, NaF; 3) exogenous S1P further
augments the pressure-induced myogenic response; 4) pressure
induces an increase in Ca
2+ concentration with the development of
myogenic tone, and the increased Ca
2+ concentration and
myogenic tone is inhibited by SKI. Exogenous S1P further
increases the pressure-induced increase in Ca
2+ concentration and
myogenic tone, but SKI has no effect. 5) pressure- and exogenous
S1P-induced myogenic tone are inhibited by pre-treatment with
fasudil, Rho kinase inhibitor, and NADPH oxidase inhibitors such
as DPI and apocynin; 6) pressure- and exogenous S1P-induced
myogenic tone are inhibited by pre-treatment with S1P receptor
blockers W146 (S1P1 receptor blocker), JTE013 (S1P2 receptor
blocker), and CAY10444 (S1P3 receptor blocker); and 7) MLC20
phosphorylation increases when transmural pressure is raised from
40 to 80 mmHg, while exogenous S1P further increases
Figure 2. The effect of endogenous and exogenous S1P on myogenic tone. A: Representative traces showing the effect of 5 mmol/L SKI on
pressure-induced myogenic tone. B: The mean data for the effects of SKI (B1; n=9), NaF (B2; n=6), and S1P (B3; n=5) on pressure-induced myogenic
tone. Changes in the lumen diameter were measured in response to 20 mmHg stepwise increases in transmural pressure in Ca
2+-containing Kreb’s-
Henseleit solution (active tone; KH) or Ca
2+-free KH solution (passive tone). C: Representative traces from five independent results showing the effect
of pre-treatment of S1P on SKI-induced inhibitory effect of myogenic tone. D: Summarized data for changes in myogenic tone during the elevation of
transmural pressure (from 40 mmHg to 80 mmHg) and application of S1P in posterior cerebral arteries with and without endothelium. S1P and
inhibitors were administered at a transmural pressure of 40 mmHg 30 min before increasing in luminal pressure. Data are expressed as means 6
SEMs (n=5–9) and are normalized to myogenic tone at a pressure of 40 mmHg. *Significantly different compared to the control (P,0.05). TMP:
transmural pressure. EC: endothelial cells.
doi:10.1371/journal.pone.0035177.g002
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phosphorylation is inhibited by pre-treatment of arteries with
SKI. Taken together, these results suggest that the SK1/S1P
pathway may play an important role in pressure-induced
myogenic responses in rabbit PCAs under normal physiological
conditions.
To determine whether endogenous S1P generated in response
to pressure was involved in myogenic vasoconstriction under
normal physiological conditions, we first determined whether SK1
was expressed and activated by pressure in isolated rabbit PCA
using western blotting and immunostaining. We detected SK1
proteins in isolated vessels including PCAs, BAs, MCAs, and ICAs
and found that SK1 was translocated from the cytosol to the
plasma membrane as a result of an increase in transmural pressure
from 40 to 80 mmHg. SK1 translocation from the cytosol to the
plasma membrane is an accepted feature of SK1 activation
[12,22]. To determine the mechanism involved in the trans-
location of SK1 by pressure elevation, we determined whether
SK1 was translocated under several conditions. Translocation of
SK1 by pressure elevation was blocked in the absence of external
Ca
2+ and in the presence of mechanosensitive ion channel
blockers, amiloride (epithelial Na
+ channel blocker) [23], 9-
phenanthrol (selective TRPM4 blocker) [24], and SKF 96365
(nonselective blocker of TRPC channels) [25]. Translocation of
SK1 by pressure elevation was also blocked in the presence of
nifedipine, voltage-sensitive Ca
2+ channel blocker. Although the
blockers used in this study have many non-specific effects, the
concentration used in the present study was reported to have no
non-specific effect. Therefore, our results suggest that SK1 activity
increases after membrane depolarization and Ca
2+ influx via
activation of voltage-sensitive Ca
2+ channels, and are consistent
with the previous findings that depolarization induces rapid and
transient formation of intracellular S1P [26].
To determine whether endogenous S1P generated by pressure
elevation plays a role in myogenic response, we evaluated the
effect of SKI, an inhibitor of SK1, and NaF, an inhibitor of SPP1,
on the pressure-induced myogenic response in rabbit PCA.
Pressure-induced myogenic tone was inhibited in rabbit PCAs
treated with SKI, but augmented by treatment with NaF. We also
investigated the effect of exogenous S1P on myogenic tone to
Figure 3. Changes in the Ca
2+ fluorescence ratio and lumen diameter during transmural pressure elevation and S1P application. A:
Representative traces demonstrate changes in the Ca
2+ ratio and lumen diameter during the elevation of transmural pressure (from 40 to 80 mmHg)
and application of S1P in the absence (A1) or presence (A2) of SKI. B: Summarized data for changes in the Ca
2+ ratio and myogenic tone during the
elevation of transmural pressure (B1) and application of S1P (B2) in the absence or presence of SKI. Data are expressed as means 6 SEMs (n=6). TMP:
transmural pressure.
doi:10.1371/journal.pone.0035177.g003
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further augmented the pressure-induced myogenic response. We
also determined the effect of pre-treatment of exogenous S1P on
the SKI-induced inhibitory effect of myogenic tone. Pre-treatment
of S1P decreased blood vessel diameter and abolished SKI-
induced inhibitory effect of myogenic tone. Taken together, our
results suggest that the elevation of transmural pressure activates
SK1 and then increases endogenous S1P. Furthermore, our results
suggest that endogenous S1P generated by pressure elevation is
involved in the development of myogenic tone in PCAs and are
consistent with the previous findings that SK1/S1P plays a specific
role as a modulator of cerebral blood flow [27].
It is well known that endothelial cells modulate vascular tone by
releasing nitric oxide. Interestingly, it has previously reported that
SK1 increases nitric oxide production by activation of endothelial
nitric oxide synthase [28]. In the present study, to determine the
role of endothelium on the SK1/S1P-induced myogenic tone, we
measured endogenous and exogenous S1P-induced myogenic tone
in PCAs with and without endothelial cells. We found that
pressure- and S1P-induced myogenic tone were not different
Figure 4. Effects of Rho kinase and NADPH oxidase inhibitors on pressure- and exogenous S1P-induced myogenic tone. A:
Representative traces demonstrate changes in lumen diameter during the elevation of transmural pressure (from 40 to 80 mmHg) and application of
S1P in the absence or presence of DPI. B: Summarized data for changes in myogenic tone during the elevation of transmural pressure and application
of S1P in the absence or presence of fasudil (B; n=5), DPI (C; n=6), or apocynin (D; n=5). Data are expressed as means 6 SEMs (n=5–6). TMP:
transmural pressure.
doi:10.1371/journal.pone.0035177.g004
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that the SKI-induced inhibitory effect of myogenic tone was
similar in endothelium denuded and intact arteries.
It is generally accepted that myogenic vasoconstriction is
mediated by a combination of elevation of cytosolic Ca
2+
concentration ([Ca
2+]i) [29,30] and Ca
2+ sensitization [20]. We
have previously reported that S1P-induced vasoconstrictions are
mediated by a combination of Ca
2+ mobilization from the
sarcoplasmic reticulum and Ca
2+ influx through L-type Ca
2+
channels in addition to a Ca
2+ sensitization mechanism [19]. In
the present study, to evaluate whether increases in [Ca
2+]i and/or
the Ca
2+ sensitization pathway contribute to the endogenous S1P-
induced myogenic tone, we first measured the effect of SKI on
changes in [Ca
2+]i and myogenic tone when the transmural
pressure was elevated. We found that pressure induced an increase
in [Ca
2+]i with subsequent development of myogenic tone, and the
increased [Ca
2+]i and myogenic tone were inhibited by SKI. We
also showed that exogenous S1P further increased the pressure-
induced increased [Ca
2+]i and myogenic tone, but SKI had no
effect. These results suggest that the increase in [Ca
2+]i involved in
myogenic vasoconstriction is mediated by endogenous S1P
generated in response to pressure elevation. However, we did
not determine the source of the [Ca
2+]i increase induced by
endogenous S1P.
We investigated the role of the Ca
2+ sensitization mechanism
in endogenous S1P-induced myogenic tone, using fasudil, DPI,
and apocynin to assess the influence of Rho A/Rho kinase and
NADPH oxidase-dependent generation of ROS. Fasudil inhib-
ited pressure- and exogenous S1P-induced myogenic tone. DPI
and apocynin also inhibited pressure- and exogenous S1P-
induced myogenic tone. These results suggest that the RhoA/
Rho-kinase and ROS-mediated Ca
2+ sensitization mechanisms
play an important role in S1P-induced myogenic tone. Our
results are consistent with the previous findings that S1P-
mediated activation of the RhoA/Rho kinase pathway is an
integral part of myogenic tone [13] and NADPH oxidase-derived
ROS production is increased in response to the elevation of
transmural pressure [31].
Figure 5. Expression of S1P receptors and effects of S1P receptor blockers on pressure- and exogenous S1P-induced myogenic
tone. A: Western blot analysis of S1P receptor expression in rabbit vessels. Representative western blots of S1P receptors and actin in isolated rabbit
posterior cerebral arteries (PCAs), basilar arteries (BAs), middle cerebral arteries (MCAs), and internal carotid arteries (ICA). B: Representative traces
demonstrate changes in lumen diameter during the elevation of transmural pressure (from 40 to 80 mmHg) and application of S1P in the absence or
presence of JTE013. C: Summarized data for changes in myogenic tone during the elevation of transmural pressure and application of S1P in the
absence or presence of W146 (C1; n=6), JTE013 (C2; n=6), and CAY10444 (C3; n=5). Data are expressed as means 6 SEMs (n=5–6). TMP: transmural
pressure.
doi:10.1371/journal.pone.0035177.g005
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PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e35177Although a link between SK1/S1P and Rho A/Rho kinase or
NADPHoxidasehasbeenidentified,wedidnotidentifythespecific
signaling mechanisms that allow for their connection. S1P is
a pleiotropic mediator and can act as both an intracellular second
messengerandanextracellularligand.Theexactsignalingtargetsof
intracellular S1P remain unidentified but extracellular S1P signals
aretransducedbyfivedistinctG-proteincoupledreceptors(S1P1–5),
which can activate small GTPases (e.g., RhoA and Rac), leading to
NADPHoxidaseactivation[12].Inthepresentstudy,weinvestigated
theroleofS1PreceptorsinendogenousandexogenousS1P-induced
myogenic tone. Although five S1P receptors (S1P1–5) have been
identified [32], three specific receptors (S1P1–3) are reportedly
expressed at the mRNA level in vascular smooth muscle [33]. We
verified that S1P1–3 are expressed at the protein level using western
blot. To determine the role of S1P receptors in endogenous and
exogenous S1P-induced myogenic tone, we tested the effects of S1P
receptor specific blockers such as W146 (S1P1 receptor blocker),
JTE013 (S1P2 receptor blocker), and CAY10444 (S1P3 receptor
blocker)onendogenousandexogenousS1P-inducedmyogenictone.
All three type-specific receptor blockers significantly inhibited both
pressure- (endogenous S1P) and exogenous S1P-induced myogenic
tone. These results suggest that endogenous S1P generated in
response to the elevation of pressure may act not only as an
intracellular second messenger, but also as an extracellular ligand
afterbeingtransportedacrosstheplasmamembrane.Intracellularly
generated S1P is unable to move through hydrophobic mammalian
cell plasma membranes since it possesses a polar head group.
Although the mechanism of S1P release from cells is not completely
understood, the involvement of the ATP-binding cassette (ABC)
familyoftransporters,especiallyABCC7(CFTR),hasbeensuggested
[14].
Smooth muscle contraction is activated primarily by phosphor-
ylation at Ser
19 of the 20 kDa regulatory light chain of myosin II.
Therefore, to directly prove that SK1/S1P plays an important role
in pressure-induced myogenic constriction under normal physio-
logical conditions, it is very important to determine the changes in
MLC20 phosphorylation during the development of myogenic
responses and the effect of SK1/S1P blockade on MLC20
phosphorylation. In the present study, we observed an increase
in MLC20 phosphorylation in rabbit PCAs when transmural
pressure or exogenous S1P was applied. The pressure-induced
increase in MLC20 phosphorylation was inhibited by pretreatment
with SKI. Thus, the data suggest that enhanced MLC20
phosphorylation in response to endogenous S1P generated by
transmural pressure elevation plays a central role in the
modulation of myogenic tone.
Based on the results of the present study, it is clear that
endogenous S1P-induced myogenic tone can be regulated by
Ca
2+-dependent and/or Ca
2+-independent (Ca
2+-sensitization)
mechanisms. Increased transmural pressure activates mechanosen-
sitive ion channels that putatively lead to Ca
2+ influx via voltage-
sensitive Ca
2+ channels and activation of SK1. SK1 converts
sphingosine to S1P. Endogenous and/or exogenous S1P then
increasetheintracellularCa
2+concentrationandmyosinlightchain
phosphorylation via activation of myosin light chain kinase. On the
other hand, extracellular S1P acts as a receptor ligand and activates
several signaling pathways, including RhoA/Rho kinase and Rac.
RhoA/Rho kinase increases apparent Ca
2+ sensitivity by inhibiting
myosin light chain phosphatase (MLCP). The activation of Rac is
associated with increased formation of O2 – via NADPH oxidase.
This pathway also modulates the apparent Ca
2+ sensitivity by
inhibiting MLCP.
In summary, our results suggest that the SK1/S1P pathway may
play an important role in pressure-induced myogenic responses in
rabbit PCAs under normal physiological conditions. S1P generated
through SK1 activation by pressure increases myogenic tone. The
underlyingmechanismsforendogenousS1P-inducedmyogenictone
are an increase in [Ca
2+]i and the Ca
2+ sensitization mechanism via
Rho A/Rho kinase and NADPH oxidase/ROS. Because endoge-
nousS1PandROSproductioniselevatedunderpathophysiological
conditionssuchashypertension,atherosclerosis,andvasospasm,the
SK1/S1P pathway likely plays an important role in myogenic tone
under pathophysiological conditions.
Author Contributions
Conceived and designed the experiments: YHL ML DSA. Performed the
experiments: ML SKC YEC SIY ECK. Analyzed the data: YHL ML SKC
YEC SIY ECK. Contributed reagents/materials/analysis tools: ML SKC
YEC SIY ECK YHL. Wrote the paper: YHL ML DSA.
Figure 6. Changes in 20-KDa myosin light chain (MLC20) phosphorylation with the elevation of transmural pressure, and the effects
of S1P or SKI application. Results are representative of immunoblots from five independent preparations. Results are expressed as means 6 SEMs
(n=5). TMP: transmural pressure.
doi:10.1371/journal.pone.0035177.g006
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